WebJan 10, 2024 · “We are thrilled to be working with Takeda to advance our GeneRide™ platform in a second indication,” said Fred Chereau, CEO of LogicBio. “Their insights … WebDec 22, 2024 · --LogicBio Therapeutics, Inc., a clinical stage genetic medicines company, today announced the appointment of Cecilia Jones as the Company's chief financial officer, effective January 11, 2024.
LogicBio Therapeutics CEO and key executive team Craft.co
WebSep 19, 2024 · Fred was Board Member at Dynacure, and President and Chief Operating Officer at aTyr Pharma. Fred Chéreau is currently President and Chief Executive Officer at LogicBio Therapeutics - View - LogicBio Therapeutics org chart Senior Vice President, Strategy & Business Development at Alexion Pharmaceuticals - View - Alexion … WebFeb 2, 2024 · Fred Chereau, LogicBio CEO. February 2, 2024 09:15 AM EST Updated 09:25 AM. Cell/Gene Tx. FDA+. FDA slams clinical hold on LogicBio's gene editing drug … dehydrator with metal shelves
Community Resources LogicBio
WebSep 19, 2024 · The colleagues of Fred Chéreau. At LogicBio Therapeutics, Fred Chéreau has 19 colleagues including Susan Kahn (Director), Richard Moscicki (Chairman of the … WebOct 3, 2024 · Fred Chereau, President and Chief Executive Officer, LogicBio, said, "Through this acquisition, we strive to accelerate our research in gene editing and AAV … WebNov 15, 2024 · LEXINGTON, Mass., December 22, 2024 - LogicBio Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today provided updates around its SUNRISE Phase 1/2 clinical trial and development pipeline, and announced the appointment of Susan R. Kahn to its Board of Directors. SUNRISE Phase 1/2 Clinical … fendt / massey ferguson powerflow 30ft